Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stability.
暂无分享,去创建一个
Varaporn Buraphacheep Junyaprasert | J. Suksiriworapong | V. Junyaprasert | Boontida Morakul | Boontida Morakul | Jiraphong Suksiriworapong | Jiraporn Leanpolchareanchai | J. Leanpolchareanchai | Jiraporn Leanpolchareanchai
[1] R. Müller,et al. Preparation and characterization of quercetin nanocrystals. , 2011, Journal of pharmaceutical sciences.
[2] Rainer H. Müller,et al. Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystal technology , 2008 .
[3] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[4] E. Forssberg,et al. Interfacial separation of particles , 2005 .
[5] R. Müller,et al. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. , 2002, International journal of pharmaceutics.
[6] Jinming Gao,et al. Nanonization strategies for poorly water-soluble drugs. , 2011, Drug discovery today.
[7] R. Davé,et al. Precipitation and stabilization of ultrafine particles of Fenofibrate in aqueous suspensions by RESOLV , 2013 .
[8] M. Mazzotti,et al. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.
[9] Patrick Augustijns,et al. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.
[10] Timo Laaksonen,et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.
[11] E. Yonemochi,et al. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] K. Amighi,et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. , 2005, International journal of pharmaceutics.
[13] Rainer H Müller,et al. State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] R. Müller,et al. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. , 2008, International journal of pharmaceutics.
[16] R. Kumria,et al. Nanocrystals: Current Strategies and Trends , 2012 .
[17] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[18] M. Gallarate,et al. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[19] S. Baumgartner,et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets. , 2009, International journal of pharmaceutics.
[20] Cornelia M Keck,et al. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. , 2004, Journal of biotechnology.
[21] J-Y Choi,et al. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. , 2008, International journal of pharmaceutics.
[22] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[23] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[24] Takuya Kumamoto,et al. Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation. , 2007, International journal of pharmaceutics.
[25] A. Drake,et al. Effect of polymer molecular weight on the production of drug nanoparticles. , 2007, Journal of pharmaceutical sciences.